Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 8—August 2002


Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan

Po-Ren Hsueh*, Lee-Jene Teng*, Cheng-Yi Chen*, Wen-Hwei Chen*, Shen-Wu Ho*Comments to Author , and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article

Table 2

Results of time-kill study of two isolates of pandrug-resistant Acinetobacter baumannii (PDRAB)

MIC (µg/mL)a
Isolate I
Isolate II
Antibiotic (clone 5) (clone 6)
Imipenem 32 32
Amikacin 128 64
Ciprofloxacin 128 2
Ampicillin-sulbactam 128 32
Imipenem + amikacin 16/64 2/4
Imipenem + ciprofloxacin 32/128 4/0.25
Imipenem + ampicillin-sulbactam 16/64 8/8
Ciprofloxacin + ampicillin-sulbactam 128/128 1/16

aValues are the lowest concentrations (µg/mL) of each agent in combination that yielded synergy.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO